Pharmacokinetics, safety and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial
Authors
Hanna, CKurian, KM
Williams, K
Watts, C
Jackson, A
Carruthers, R
Strathdee, K
Cruickshank, G
Dunn, L
Erridge, S
Godfrey, L
Jefferies, S
McBain, Catherine A
Sleigh, R
McCormick, A
Pittman, M
Halford, S
Chalmers, AJ
Affiliation
Institute of Cancer Sciences, University of Glasgow, United Kingdom.Issue Date
2020
Metadata
Show full item recordCitation
Hanna C, Kurian KM, Williams K, Watts C, Jackson A, Carruthers R, et al. Pharmacokinetics, safety and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro Oncol. 2020.Journal
Neuro-OncologyDOI
10.1093/neuonc/noaa104PubMed ID
32347934Additional Links
https://dx.doi.org/ 10.1093/neuonc/noaa104Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/neuonc/noaa104
Scopus Count
Collections
Related articles
- Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
- Authors: Lesueur P, Lequesne J, Grellard JM, Dugué A, Coquan E, Brachet PE, Geffrelot J, Kao W, Emery E, Berro DH, Castera L, Goardon N, Lacroix J, Lange M, Capel A, Leconte A, Andre B, Léger A, Lelaidier A, Clarisse B, Stefan D
- Issue date: 2019 Mar 4
- The Combination PARP Inhibitor Olaparib With Temozolomide in an Experimental Glioblastoma Model.
- Authors: Hwang K, Lee JH, Kim SH, Go KO, Ji SY, Han JH, Kim CY
- Issue date: 2021 Jul-Aug
- Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells.
- Authors: Zampieri LX, Sboarina M, Cacace A, Grasso D, Thabault L, Hamelin L, Vazeille T, Dumon E, Rossignol R, Frédérick R, Sonveaux E, Lefranc F, Sonveaux P
- Issue date: 2021 Nov 3
- Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo.
- Authors: van Erp AEM, van Houdt L, Hillebrandt-Roeffen MHS, van Bree NFHN, Flucke UE, Mentzel T, Shipley J, Desar IME, Fleuren EDG, Versleijen-Jonkers YMH, van der Graaf WTA
- Issue date: 2020 Jul
- A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report.
- Authors: Su JM, Thompson P, Adesina A, Li XN, Kilburn L, Onar-Thomas A, Kocak M, Chyla B, McKeegan E, Warren KE, Goldman S, Pollack IF, Fouladi M, Chen A, Giranda V, Boyett J, Kun L, Blaney SM
- Issue date: 2014 Dec